Update in the treatment of non-influenza respiratory virus infection in solid organ transplant recipients. (Q38829076)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28425766 AND SRC:MED&resulttype=core&format=json

18 March 2020

title

Update in the treatment of non-influenza respiratory virus infection in solid organ transplant recipients (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28425766 AND SRC:MED&resulttype=core&format=json

18 March 2020

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28425766 AND SRC:MED&resulttype=core&format=json

18 March 2020

author name string

Shellee A Grim

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28425766 AND SRC:MED&resulttype=core&format=json

18 March 2020

Gail E Reid

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28425766 AND SRC:MED&resulttype=core&format=json

18 March 2020

language of work or name

English

0 references

publication date

28 April 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28425766 AND SRC:MED&resulttype=core&format=json

Expert Opinion on Pharmacotherapy

18 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28425766 AND SRC:MED&resulttype=core&format=json

18 March 2020

volume

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28425766 AND SRC:MED&resulttype=core&format=json

18 March 2020

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28425766 AND SRC:MED&resulttype=core&format=json

18 March 2020

page(s)

767-779

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28425766 AND SRC:MED&resulttype=core&format=json

Newer respiratory virus infections: human metapneumovirus, avian influenza virus, and human coronaviruses.

18 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1080/14656566.2017.1322063

RNA respiratory viruses in solid organ transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14656566.2017.1322063

Outcomes from pandemic influenza A H1N1 infection in recipients of solid-organ transplants: a multicentre cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14656566.2017.1322063

Respiratory viruses in lung transplant recipients: a critical review and pooled analysis of clinical studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14656566.2017.1322063

Epidemiology and Immediate Indirect Effects of Respiratory Viruses in Lung Transplant Recipients: A 5-Year Prospective Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14656566.2017.1322063

Multiplex PCR and Emerging Technologies for the Detection of Respiratory Pathogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14656566.2017.1322063

Detection of respiratory viruses by molecular methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14656566.2017.1322063

A newly discovered human pneumovirus isolated from young children with respiratory tract disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14656566.2017.1322063

Community respiratory virus infections following lung transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14656566.2017.1322063

Clinical implications of respiratory virus infections in solid organ transplant recipients: a prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14656566.2017.1322063

Respiratory Tract Infections Due to Human Metapneumovirus in Immunocompromised Children

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14656566.2017.1322063

Treatment of adenovirus pneumonia with cidofovir in pediatric lung transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14656566.2017.1322063

A surveillance study of adenovirus infection in adult solid organ transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14656566.2017.1322063

The human metapneumovirus: a case series and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14656566.2017.1322063

Recovery of drug-resistant influenza virus from immunocompromised patients: a case series

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14656566.2017.1322063

2007 Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Health Care Settings

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14656566.2017.1322063

Invasive aspergillosis in allogeneic stem cell transplant recipients: changes in epidemiology and risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14656566.2017.1322063

Human metapneumovirus pneumonia in adults: results of a prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14656566.2017.1322063

A patient self-collection method for longitudinal monitoring of respiratory virus infection in solid organ transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14656566.2017.1322063

A single-season prospective study of respiratory viral infections in lung transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14656566.2017.1322063

Clinical impact of community-acquired respiratory viruses on bronchiolitis obliterans after lung transplant.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14656566.2017.1322063

Incidence and morbidity of human metapneumovirus and other community-acquired respiratory viruses in lung transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14656566.2017.1322063

Clinical features and outcomes of paramyxoviral infection in lung transplant recipients treated with ribavirin

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14656566.2017.1322063

Single-centre experience with oral ribavirin in lung transplant recipients with paramyxovirus infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14656566.2017.1322063

Current practices for treatment of respiratory syncytial virus and other non-influenza respiratory viruses in high-risk patient populations: a survey of institutions in the Midwestern Respiratory Virus Collaborative.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14656566.2017.1322063

Diagnostic performance of two highly multiplexed respiratory virus assays in a pediatric cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14656566.2017.1322063

Adenovirus in solid organ transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14656566.2017.1322063

European guidelines for diagnosis and treatment of adenovirus infection in leukemia and stem cell transplantation: summary of ECIL-4 (2011).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14656566.2017.1322063

Assessment of adenovirus infection in adult lung transplant recipients using molecular surveillance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14656566.2017.1322063

Adenoviruses in immunocompromised hosts

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14656566.2017.1322063

Monitoring of adenovirus (ADV)-specific T cells in a boy with ADV pneumonia and disseminated disease after lung transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14656566.2017.1322063

New drug on the horizon for treating adenovirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14656566.2017.1322063

Monitoring of adenovirus infection in pediatric transplant recipients by quantitative PCR: report of six cases and review of the literature.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14656566.2017.1322063

Clinical pharmacokinetics of the antiviral nucleotide analogues cidofovir and adefovir

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14656566.2017.1322063

Successful cidofovir treatment in an adult heart transplant recipient with severe adenovirus pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14656566.2017.1322063

Disseminated adenovirus infection in renal transplant recipients: the role of cidofovir and intravenous immunoglobulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14656566.2017.1322063

Early diagnosis of adenovirus infection and treatment with cidofovir after bone marrow transplantation in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14656566.2017.1322063

Real-time blood plasma polymerase chain reaction for management of disseminated adenovirus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14656566.2017.1322063

Development of CMX001 (Brincidofovir) for the treatment of serious diseases or conditions caused by dsDNA viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14656566.2017.1322063

Safety and efficacy of CMX001 as salvage therapy for severe adenovirus infections in immunocompromised patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14656566.2017.1322063

Oral Ribavirin for the Treatment of Noninfluenza Respiratory Viral Infections: A Systematic Review

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14656566.2017.1322063

Valganciclovir inhibits human adenovirus replication and pathology in permissive immunosuppressed female and male Syrian hamsters

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14656566.2017.1322063

Effect of hypogammaglobulinemia on the incidence of community-acquired respiratory viral infections after lung transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14656566.2017.1322063

Activity of broad-spectrum T cells as treatment for AdV, EBV, CMV, BKV, and HHV6 infections after HSCT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14656566.2017.1322063

Clinical and radiological features of respiratory syncytial virus in solid organ transplant recipients: a single‐center experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14656566.2017.1322063

Community-acquired pneumonia requiring hospitalization among U.S. children

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14656566.2017.1322063

Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14656566.2017.1322063

The impact of RSV, adenovirus, influenza, and parainfluenza infection in pediatric patients receiving stem cell transplant, solid organ transplant, or cancer chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14656566.2017.1322063

Oral ribavirin for respiratory syncytial virus infection after lung transplantation: Efficacy and cost-efficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14656566.2017.1322063

Intravenous ribavirin is a safe and cost-effective treatment for respiratory syncytial virus infection after lung transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14656566.2017.1322063

A multi-drug regimen for respiratory syncytial virus and parainfluenza virus infections in adult lung and heart-lung transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14656566.2017.1322063

Adult patients with respiratory syncytial virus infection: impact of solid organ and hematopoietic stem cell transplantation on outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14656566.2017.1322063

Morbidity and mortality among patients with respiratory syncytial virus infection: a 2-year retrospective review

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14656566.2017.1322063

Prolonged respiratory viral shedding in transplant patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14656566.2017.1322063

Oral versus inhaled ribavirin therapy for respiratory syncytial virus infection after lung transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14656566.2017.1322063

Efficacy of oral ribavirin in lung transplant patients with respiratory syncytial virus lower respiratory tract infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14656566.2017.1322063

Low incidence of severe respiratory syncytial virus infections in lung transplant recipients despite the absence of specific therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14656566.2017.1322063

Comparison of the inhibition of human metapneumovirus and respiratory syncytial virus by ribavirin and immune serum globulin in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14656566.2017.1322063

Randomized controlled multicenter trial of aerosolized ribavirin for respiratory syncytial virus upper respiratory tract infection in hematopoietic cell transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14656566.2017.1322063

Impact of aerosolized ribavirin on mortality in 280 allogeneic haematopoietic stem cell transplant recipients with respiratory syncytial virus infections.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14656566.2017.1322063

Health care worker exposure to aerosolized ribavirin: biological and air monitoring

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14656566.2017.1322063

Respiratory syncytial virus prophylaxis: a survey of pediatric solid organ transplant centers

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14656566.2017.1322063

Ultra-potent antibodies against respiratory syncytial virus: effects of binding kinetics and binding valence on viral neutralization

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14656566.2017.1322063

Motavizumab for prophylaxis of respiratory syncytial virus in high-risk children: a noninferiority trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14656566.2017.1322063

Compassionate use experience with high-titer respiratory syncytical virus (RSV) immunoglobulin in RSV-infected immunocompromised persons

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14656566.2017.1322063

Discovery of an oral respiratory syncytial virus (RSV) fusion inhibitor (GS-5806) and clinical proof of concept in a human RSV challenge study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14656566.2017.1322063

GS-5806 Inhibits a Broad Range of Respiratory Syncytial Virus Clinical Isolates by Blocking the Virus-Cell Fusion Process

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14656566.2017.1322063

Activity of Oral ALS-008176 in a Respiratory Syncytial Virus Challenge Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14656566.2017.1322063

A randomized, double-blind, placebo-controlled study of an RNAi-based therapy directed against respiratory syncytial virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14656566.2017.1322063

ALN-RSV01 for prevention of bronchiolitis obliterans syndrome after respiratory syncytial virus infection in lung transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14656566.2017.1322063

Human metapneumovirus infection in hematopoietic stem cell transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14656566.2017.1322063

Fatal human metapneumovirus infection following allogeneic hematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14656566.2017.1322063

Human metapneumovirus infection after allogeneic hematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14656566.2017.1322063

Treatment of severe human metapneumovirus (hMPV) pneumonia in an immunocompromised child with oral ribavirin and IVIG.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14656566.2017.1322063

A broadly neutralizing human monoclonal antibody exhibits in vivo efficacy against both human metapneumovirus and respiratory syncytial virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14656566.2017.1322063

Community-acquired respiratory syncytial virus and parainfluenza virus infections after hematopoietic stem cell transplantation: the Fred Hutchinson Cancer Research Center experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14656566.2017.1322063

Lower respiratory tract viral infections in pediatric abdominal organ transplant recipients: a single hospital inpatient cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14656566.2017.1322063

The epidemiology of parainfluenza virus infection in lung transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14656566.2017.1322063

In vitro and in vivo effect of 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide (ribavirin) on types 1 and 3 parainfulenza virus infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14656566.2017.1322063

A recombinant sialidase fusion protein effectively inhibits human parainfluenza viral infection in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14656566.2017.1322063

DAS181 for Treatment of Parainfluenza Virus Infections in Hematopoietic Stem Cell Transplant Recipients at a Single Center

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14656566.2017.1322063

DAS181 treatment of severe parainfluenza type 3 pneumonia in a lung transplant recipient

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14656566.2017.1322063

Human parainfluenza virus-3 can be targeted by rapidly ex vivo expanded T lymphocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14656566.2017.1322063

Incidence and outcomes of respiratory viral infections in lung transplant recipients: a prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14656566.2017.1322063

Efficacy and safety of oral pleconaril for treatment of colds due to picornaviruses in adults: results of 2 double-blind, randomized, placebo-controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14656566.2017.1322063

2-Ethoxybenzoxazole as a bioisosteric replacement of an ethyl benzoate group in a human rhinovirus (HRV) capsid binder

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14656566.2017.1322063

Clinical Efficacy of Therapy with Recombinant Human Interferon α1b in Hand, Foot, and Mouth Disease with Enterovirus 71 Infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14656566.2017.1322063

The effect of inhaled IFN-β on worsening of asthma symptoms caused by viral infections. A randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14656566.2017.1322063

Biologic targeted therapy in allergic asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14656566.2017.1322063

Combating enterovirus replication: State-of-the-art on antiviral research

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14656566.2017.1322063

Rhinovirus and coronavirus infection-associated hospitalizations among older adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14656566.2017.1322063

Repurposing of clinically developed drugs for treatment of Middle East respiratory syndrome coronavirus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14656566.2017.1322063

Outbreak of Middle East respiratory syndrome coronavirus in Saudi Arabia: a retrospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14656566.2017.1322063

MERS CoV infection in two renal transplant recipients: case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14656566.2017.1322063

Ribavirin and interferon alfa-2a for severe Middle East respiratory syndrome coronavirus infection: a retrospective cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14656566.2017.1322063

Ribavirin and interferon therapy in patients infected with the Middle East respiratory syndrome coronavirus: an observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14656566.2017.1322063

Correlation of rhinovirus load in the respiratory tract and clinical symptoms in hospitalized immunocompetent and immunocompromised patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14656566.2017.1322063

Molecular quantification of respiratory syncytial virus in respiratory samples: reliable detection during the initial phase of infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14656566.2017.1322063

The time is now: moving toward virus-specific T cells after allogeneic hematopoietic stem cell transplantation as the standard of care

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14656566.2017.1322063

Infectious disease. Combating emerging viral threats

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14656566.2017.1322063

Suppression of coronavirus replication by cyclophilin inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14656566.2017.1322063

Clinical potential of DAS181 for treatment of parainfluenza-3 infections in transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14656566.2017.1322063

Respiratory viral infections in transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14656566.2017.1322063

A Prospective Molecular Surveillance Study Evaluating the Clinical Impact of Community-Acquired Respiratory Viruses in Lung Transplant Recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14656566.2017.1322063

Respiratory syncytial virus--United States, July 2012-June 2014.

21 January 2018

1 reference

12 December 2020

Detection of human rhinoviruses in the lower respiratory tract of lung transplant recipients

1 reference

12 December 2020

Human rhinovirus C: a newly discovered human rhinovirus species

1 reference

12 December 2020

FDA panel rejects common cold treatment

1 reference

12 December 2020

Adenovirus infection in the lung results in graft failure after lung transplantation

1 reference

12 December 2020

Immune reconstitution and clearance of human adenovirus viremia in pediatric stem-cell recipients

1 reference

12 December 2020

Activity of pleconaril against enteroviruses

1 reference

12 December 2020

Double blind placebo-controlled trial of pleconaril in infants with enterovirus meningitis

1 reference

12 December 2020

In vitro susceptibility of adenovirus to antiviral drugs is species-dependent.

1 reference

12 December 2020

Lethal hemorrhagic alveolitis after adenovirus pneumonia in a lung transplant recipient

1 reference

12 December 2020

Paramyxovirus infection in lung transplant recipients

1 reference

12 December 2020

Management of respiratory viral infections in hematopoietic cell transplant recipients

1 reference

12 December 2020

Respiratory syncytial virus-associated infections in adult recipients of solid organ transplants

1 reference

12 December 2020

Respiratory syncytial virus pneumonia treated with lower-dose palivizumab in a heart transplant recipient

1 reference

12 December 2020

Use of cidofovir in pediatric patients with adenovirus infection

1 reference

12 December 2020

Coronavirus-associated pneumonia in previously healthy children

1 reference

12 December 2020